Exbivirumab is an investigational monoclonal antibody used in HepeX-B, a drug containing two human monoclonal antibodies targeting the hepatitis B virus (HBV) surface antigen. The DrugMonitor™ Anti-Exbivirumab Antibody (VS-1224-YC461) is an anti-drug antibody (ADA) against Exbivirumab. This drug-based antibody is raised in mice immunized with the Exbivirumab. The anti-Exbivirumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Exbivirumab in samples.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Anti-HBV Recombinant Antibody (Exbivirumab)Recombinant human monoclonal antibody expressed in CHO binding to HBV. Exbivirumab is a human monoclonal antibody developed for the treatment of hepatitis B infections.
Afuco™ Anti-HBV ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-746)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to HBV. It is a human monoclonal antibody developed for the treatment of hepatitis B infections.
There are currently no Customer reviews or questions for VS-1224-YC461. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.